Additionally, TGF-β receptor inhibitors (e.g., SB525334) and MMP inhibitors (e.g., Marimastat) could attenuate GDF15-induced eCAF activation, thereby reducing the supportive role of the TME in GC metastasis. The gene discussed is GDF15; the disease is gastric cancer.